Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amogh Amopect ES Syrup is an Ayurvedic polyherbal formulation developed by Amogh Pharmaceuticals for the management of respiratory ailments. It is primarily indicated for the relief of various types of cough, including dry, productive, and allergic cough, as well as symptoms of bronchitis and the common cold. The syrup is composed of several traditional Indian medicinal herbs, such as Vasaka (Adhatoda vasica), Tulsi (Ocimum sanctum), and Yashtimadhu (Glycyrrhiza glabra), which provide expectorant, antitussive, and bronchodilatory effects. As a consumer health product, it is marketed for its ability to soothe the throat and facilitate the expulsion of mucus without causing drowsiness, a common side effect of synthetic cough suppressants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amogh Amopect ES Syrup.